Published in Urologiia on March 23, 2011
[Transurethral electroresection of prostatic adenoma under transrectal ultrasonic control]. Urologiia (2006) 0.84
[Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial]. Urologiia (2006) 0.84
[Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)]. Urologiia (2002) 0.81
Liposoluble vitamins E and A in human renal cortex and renal cell carcinomas. Nephron (1995) 0.79
[Viagra, cialis, impase--which of them, to whom, when and how?]. Urologiia (2004) 0.79
[Imperative and obstructive urination disorders in patients with chronic inflammatory diseases of the urinary tract]. Urologiia (2013) 0.78
[The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia]. Urologiia (2013) 0.78
[Background and precancerous processes in renal cell carcinoma]. Arkh Patol (1989) 0.78
Method of choice for urinary diversion in surgical treatment of bladder carcinoma. Int Urol Nephrol (1976) 0.77
[Three-dimentional echography in diagnosis and staging of urinary bladder cancer]. Urologiia (2005) 0.77
[Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma]. Urologiia (2009) 0.77
Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer. Prostate (2014) 0.76
[Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions]. Urologiia (2007) 0.76
Nephrectomy with prior intraluminal balloon occlusion of the renal artery in kidney cancer. Eur Urol (1979) 0.76
[Temporary sacral and tibial neuromodulation in treating patients with overactive urinary bladder]. Zh Vopr Neirokhir Im N N Burdenko (2002) 0.76
[Afferent stimulation of the tibial nerve in patients with hyperactive bladder]. Urologiia (2002) 0.76
[Experimental validation of the developing a matrix based on decellularized vascular wall for subsequent substitution urethroplasty]. Urologiia (2015) 0.75
[Retroperitoneal fibrosis: Ormond's disease]. Urol Nefrol (Mosk) (1980) 0.75
[Function of contralateral kidney in unilateral renal disease]. Sov Med (1976) 0.75
[Current methods of study of blood coagulation disorders in patients with prostatic adenoma]. Urol Nefrol (Mosk) (1984) 0.75
[Diagnosis of the "valve effect" of the middle lobe of prostate in benign prostatic hyperplasia and choice of the treatment method]. Urol Nefrol (Mosk) (1998) 0.75
[Nephropexy by Rivoir's method in the Pytel'-Lopatkin modification]. Urol Nefrol (Mosk) (1975) 0.75
[Omnic (tamsulosin) in the treatment of benign prostatic hyperplasia]. Urologiia (2001) 0.75
[The holmium laser in the treatment of bladder cancer patients]. Urol Nefrol (Mosk) (1996) 0.75
[Indications for certain methods of urinary diversion after cystectomy of exclusion of the urinary bladder]. Urol Nefrol (Mosk) (1975) 0.75
[Surgical treatment of patients with a tumor of the single and of both kidneys]. Klin Khir (1979) 0.75
The role of arterial pressure dynamics in the diagnosis of renal graft rejection crisis. Int Urol Nephrol (1972) 0.75
[Roentgeno-radioisotope methods in recognition of closed injuries of the kidneys]. Vestn Khir Im I I Grek (1977) 0.75
[The use of the holmium laser for treating strictures of the urethra and bladder neck in men]. Urol Nefrol (Mosk) (1997) 0.75
[Endoscopic ureterolithotripsy with the holmium laser]. Urol Nefrol (Mosk) (1997) 0.75
[Contralateral kidney function in unilateral recurrent nephrolithiasis]. Urol Nefrol (Mosk) (1981) 0.75
[Radioisotope renal cystography]. Med Radiol (Mosk) (1974) 0.75
[The Pytel'-Lopatkin modification of the Rivoir nephropexy]. Urol Nefrol (Mosk) (1969) 0.75
[Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis]. Urologiia (2001) 0.75
[Transverse ureterolithotomy]. Urol Nefrol (Mosk) (1985) 0.75
[Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia]. Urol Nefrol (Mosk) (1998) 0.75
[Identification physico-chemical properties and immunochemical characteristic of prostate specific antigen and its complexes with protease inhibitors]. Vopr Med Khim (1997) 0.75
[The treatment of patients with benign prostatic hyperplasia using the selective alpha-blocker alfuzosin]. Ter Arkh (1997) 0.75
[Characteristics of various surgical technics in vasorenal arterial hypertension]. Urol Nefrol (Mosk) (1985) 0.75
[Characteristics of the blood proteinogram in kidney cancer]. Urol Nefrol (Mosk) (1979) 0.75
[New developments in phytotherapy of chronic prostatitis (a lecture)]. Ter Arkh (2001) 0.75
[Diagnosis and treatment of retroperitoneal fibrosis (Ormond's disease)]. Urol Nefrol (Mosk) (1982) 0.75
[Urotractin in the treatment of an infection of the kidneys, urinary tract and prostate]. Urol Nefrol (Mosk) (1997) 0.75
[Sildenafil and alprostadil in the combined drug therapy of erectile dysfunction]. Urologiia (2002) 0.75
[Dose correcting factors in the treatment of erectile dysfunction with viagra]. Urologiia (2001) 0.75
[Aneurysm of the renal artery]. Urol Nefrol (Mosk) (1970) 0.75
[Developmental variants in the renocaval portion of the venous system and their clinical importance]. Urol Nefrol (Mosk) (1976) 0.75
[Indications for the transfistular removal of kidney stones]. Urol Nefrol (Mosk) (1987) 0.75
[Ho-YAG laser endoscopic treatment of ureteral strictures]. Urologiia (2001) 0.75
[Nephroptosis and arterial hypertension (experimental study)]. Urol Nefrol (Mosk) (1972) 0.75
[Adenoma and carcinoma of the prostate]. Feldsher Akush (1973) 0.75
[Surgical treatment of acute priapism]. Urol Nefrol (Mosk) (1981) 0.75
[Results of the clinical use of catapressan in arterial hypertension]. Ter Arkh (1974) 0.75
[Arterial hypertension as a consequence of chronic pyelonephritis]. Urol Nefrol (Mosk) (1983) 0.75
[Extracorporeal surgery of the kidney in the treatment of vasorenal hypertension]. Urol Nefrol (Mosk) (1977) 0.75
[Surgical treatment of cancer of a single or both kidneys]. Urol Nefrol (Mosk) (1984) 0.75
[Electromyographic evidence in conservative treatment of stress enuresis in women]. Urologiia (2001) 0.75
[Value of radiodiangostic indices in chronic renal insufficiency]. Med Radiol (Mosk) (1972) 0.75
[Temporary sacral neuromodulation in patients with urge incontinence]. Urologiia (2000) 0.75
[Diagnosis of vasorenal hypertension (review of the foreign literature)]. Urol Nefrol (Mosk) (1970) 0.75
[Radioisotopic diagnosis of carbuncle of the kidney]. Urol Nefrol (Mosk) (1977) 0.75
[Causes of arterial hypertension and tactics of its treatment in chronic renal insufficiency at the terminal stage]. Sov Med (1975) 0.75
[MRI of penis and pelvic floor in examination of erectile dysfunction pathogenesis in patients after perineal blunt injury and choice of treatment policy]. Urologiia (2000) 0.75
[Diagnostic and prognostic significance of paraneoplastic signs of kidney cancer]. Sov Med (1983) 0.75
[The role of disorders of mineralocorticoid function of the adrenal glands in the development of infertility in patients with left-side varicocele]. Urol Nefrol (Mosk) (1989) 0.75
[The role of the functional interrelation of the adrenals and testes in the pathogenesis of sterility in patients with left-sided varicocele]. Urol Nefrol (Mosk) (1990) 0.75
[Radioisotope lower venography in bladder neoplasms]. Urol Nefrol (Mosk) (1976) 0.75
[Contralateral kidney function in unilateral nephroureterolithiasis]. Sov Med (1978) 0.75
[The use of serpens for treating patients with benign prostatic hyperplasia]. Ter Arkh (1996) 0.75
[Clinical, laboratory and morphological features of prostatic precancer]. Urologiia (2000) 0.75
[Finasteride in prolonged therapy of patients with benign prostatic hyperplasia]. Urologiia (2001) 0.75
[Pharmaco-profilometry using alpha-1a adrenergic blockers in the diagnosis of dynamic infravesical obstruction in the vesicourethral zone segment]. Urol Nefrol (Mosk) (1999) 0.75
[Electromyography of the penis in the diagnosis of erectile dysfunction after radical operations on the organs of the lesser pelvis]. Urol Nefrol (Mosk) (1998) 0.75
[Experimental modeling of retroperitoneal fibrosis]. Urol Nefrol (Mosk) (1981) 0.75
[The effect of renal arterio- and phlebography on the function of the renin-angiotensin and hypophyseal-adrenal systems]. Urol Nefrol (Mosk) (1990) 0.75
[Diagnosis of vasorenal arterial hypertension and the selection of a therapeutic method]. Urol Nefrol (Mosk) (1987) 0.75
[Ultrasonic scanning of the kidneys, prostate gland and urinary bladder in inpatient screening]. Urol Nefrol (Mosk) (1985) 0.75
[Clinical morphological basis for a kidney autograft in the treatment of renovascular arterial hypertension]. Urol Nefrol (Mosk) (1981) 0.75
[Paraneoplastic manifestations of kidney cancer]. Urol Nefrol (Mosk) (1981) 0.75
[Errors in the diagnosis of kidney cancer and their prevention]. Urol Nefrol (Mosk) (1985) 0.75
[Temporary ureteral stents in patients with neuorgenic dysfunction of the urinary bladder]. Urologiia (2002) 0.75
[Vesico-ureteral reflux and arterial hypertension]. Urol Nefrol (Mosk) (1987) 0.75
[Sacral nerve stimulation in the treatment of urination disorders and pelvic pain]. Urol Nefrol (Mosk) (1998) 0.75
[A delegation of Soviet urologists in Belgium]. Urol Nefrol (Mosk) (1990) 0.75
[Clinicomorphological characteristics of fibromuscular dysplasia of the renal artery accompanied by hypertension]. Arkh Patol (1972) 0.75
[Kidney injury as a cause of arterial hypertension]. Urol Nefrol (Mosk) (1970) 0.75
[External prosthesis of the ureter in retroperitoneal fibrosis]. Urol Nefrol (Mosk) (1986) 0.75
[Atypical course of primary aldosteronism]. Sov Med (1971) 0.75
[Recognition of kidneys neoformatims by ultrasonic scanning]. Urol Nefrol (Mosk) (1977) 0.75